Deep Learning Predicts Lymphovascular Invasion Status in Muscle Invasive Bladder Cancer Histopathology.

Abstract

Background: Lymphovascular invasion (LVI) is linked to poor prognosis in patients with muscle-invasive bladder cancer (MIBC). Accurately identifying the LVI status in MIBC patients is crucial for effective risk stratification and precision treatment. We aim to develop a deep learning model to identify the LVI status in whole-slide images (WSIs) of MIBC patients.

Patients and methods: A cohort from The Cancer Genome Atlas (TCGA) database was used to train a deep learning model, slide-based lymphovascular invasion predictor (SBLVIP), based on multiple-instance learning. This model was externally validated using the Renmin Hospital of Wuhan University (RHWU) and People's Hospital of Hanchuan City (PHHC) cohorts. Kaplan-Meier curves, along with univariate and multivariate Cox models, were employed to evaluate the association between the LVI status predicted by SBLVIP and the survival outcomes of MIBC patients.

Results: In the TCGA cohort, the SBLVIP model achieved an average accuracy of 0.804 [95% confidence interval (CI) 0.712-0.895] and an area under the receiver operating characteristic curve (AUC) of 0.77 (95% CI 0.63-0.84) in the training set. In the internal validation set, the model's average accuracy and AUC were 0.774 (95% CI, 0.701-0.846) and 0.76 (95% CI, 0.60-0.83), respectively. In the RHWU cohort, the SBLVIP model achieved an average accuracy of 0.807 (95% CI 0.734-0.880) and an AUC of 0.74 (95% CI 0.55-0.83). In the PHHC cohort, SBLVIP demonstrated an average accuracy of 0.821 (95% CI 0.737-0.909) and an AUC of 0.74 (95% CI 0.58-0.89). Moreover, the LVI status predicted by SBLVIP showed significant independent prognostic value (P = 1 × 10^-6).

Conclusions: We developed a deep learning model named SBLVIP to predict the LVI status in routine WSIs of MIBC patients.